Google
×
Conclusion. Discontinuation of long-term biperiden use may be warranted in patients with schizophrenia treated with SGAs, as it may improve cognitive function, subjective QOL, and psychiatric symptoms with no significant adverse effects.
People also ask
Jan 15, 2011 · Discontinuation of long-term biperiden use may be warranted in patients with schizophrenia treated with SGAs, as it may improve cognitive function, subjective ...
Dec 1, 1999 · Biperiden produced a significant increase in positive symptoms and a decrease in negative symptoms. REM latency was significantly shorter in ...
In the majority of the patients no clinically apparent discomfort was observed, and only two of 21 placebo patients developed extrapyramidal side effects (EPS) ...
Biperiden in the Treatment of Cocaine/Crack Dependence In schizophrenic patients, the relief of negative symptoms and the inhibition of the anhedonia caused by ...
Jun 13, 2005 · Biperiden is a muscarinic receptor antagonist used to treat parkinsonism and control extrapyramidal side effects of neuroleptic drugs.
Sep 19, 2013 · Biperiden (4 mg/day) treatment for 2 weeks was associated with poorer memory performance than amantadine (200 mg/day) treatment, particularly ...
Biperiden is used to treat the stiffness, tremors, spasms, and poor muscle control of Parkinson's disease.
Feb 26, 2008 · Anticholinergic drugs such as biperiden are used for the treatment of extrapyramidal side effects (EPS) induced by neuroleptics such as ...
Two cases of schizophrenia are reported in which insomnia developed after biperiden withdrawal or reduction.